The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors
about
Gram-positive and gram-negative bacterial toxins in sepsis: a brief reviewVascular endothelial dysfunction and pharmacological treatmentProtective effects of a leukotriene inhibitor and a leukotriene antagonist on endotoxin-induced mortality in carrageenan-pretreated mice.Sequential release of tumour necrosis factor, platelet activating factor and eicosanoids during endotoxin shock in anaesthetized pigs: protective effects of indomethacinTumor necrosis factor induces glomerular damage in the rabbit.Skin test performed with highly purified Mycobacterium tuberculosis recombinant protein triggers tuberculin shock in infected guinea pigsCellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.Role of inflammatory mediators in resistance and susceptibility to pneumococcal infection.Acute effects of tumor necrosis factor on the microcirculation in rat cremaster muscle.Administration of endotoxin, tumor necrosis factor, or interleukin 1 to rats activates skeletal muscle branched-chain alpha-keto acid dehydrogenase.Tumor necrosis factor alpha and the anemia associated with murine malaria.Inhibition of growth of Chlamydia trachomatis by tumor necrosis factor is accompanied by increased prostaglandin synthesisSelective modulation of lipopolysaccharide-induced death and cytokine production by various muramyl peptidesActivation of protein breakdown and prostaglandin E2 production in rat skeletal muscle in fever is signaled by a macrophage product distinct from interleukin 1 or other known monokines.Tumor necrosis factor can induce fever in rats without activating protein breakdown in muscle or lipolysis in adipose tissueIn vivo evaluation of ocular inflammatory responses in experimental diabetes.Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs.Relationships between tumour necrosis factor, eicosanoids and platelet-activating factor as mediators of endotoxin-induced shock in mice.Reduction of interstitial fluid pressure after TNF-alpha treatment of three human melanoma xenografts.Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice.Circadian dynamics of tumor necrosis factor alpha (cachectin) lethality.Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumourInduction of weight loss and metabolic alterations by human recombinant tumour necrosis factor.Role of prostaglandins in tumour necrosis factor induced weight lossAdrenocorticotropic hormone ameliorates acute kidney injury by steroidogenic-dependent and -independent mechanismsRole of arachidonic acid metabolism in transcriptional induction of tumor necrosis factor gene expression by phorbol esterInduction of circulating tumor necrosis factor cannot be demonstrated during septicemic salmonellosis in calves.The diverse roles of the TNF axis in cancer progression and metastasis.A proinflammatory mediator with potential relevance in aging.The anticancer drug mithramycin A sensitises tumour cells to apoptosis induced by tumour necrosis factor (TNF).Binding of lysozyme to lipopolysaccharide suppresses tumor necrosis factor production in vivo.Compensatory anabolic signaling in the sarcopenia of experimental chronic arthritis.In vivo effects of the antiglucocorticoid RU 486 on glucocorticoid and cytokine responses to Escherichia coli endotoxin.An antagonist of platelet-activating factor suppresses endotoxin-induced tumor necrosis factor and mortality in mice pretreated with carrageenan.Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexiaTumor necrosis factor inhibits human myogenesis in vitroProtective effect of NG-monomethyl-L-arginine against hypotension inducted by combined tumour necrosis factor-alpha and whole body hyperthermia in rats.Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.Tumour necrosis factor-alpha (TNF-alpha): the good, the bad and potentially very effective.Safe TNF-based antitumor therapy following p55TNFR reduction in intestinal epithelium
P2860
Q22305427-C3D953F4-F382-496E-9A46-05EF5FC76E51Q26774561-6FADA5B0-13CD-4F2B-849A-9C88A43FC109Q33366153-9DDCC3D2-52E1-4F0B-9226-80A8DCD8860DQ33377217-B22A4D1F-57CD-41E4-97B9-FB46A1FAFC62Q33444321-14AD3F5C-62FA-4C44-B84D-73238C0FEBEEQ33788281-0C81064D-16D6-443F-977B-7E7A49E74179Q33907789-1D628D72-6885-4F8F-B4E0-F733B919FFFFQ34120542-644417D2-7B24-4FD0-B428-0FC23004F2B5Q34187040-FE5A9015-8F4E-46DF-B2A8-10D6F8B743E5Q34240870-60E495DF-07C4-4316-A58E-65A37D350BE3Q35095995-A8FE0052-701B-46F7-A8B3-6AFD553C67ECQ35105367-E65A38AB-0EEA-4E36-8983-EBFC45BCDD20Q35378360-B0026AEE-894B-4F78-9373-D90BDC15B793Q35587669-78BC142E-8D66-4C9A-B21C-A15F7C54A87DQ35587712-92A43C9A-CB4E-4D87-A2DE-D8E354F70089Q35593499-BD5F5FA9-7929-47EC-8F8D-26058BA978A1Q35604862-03643321-F2B0-4648-A0C6-35410B0974B5Q35887741-53DCAAAB-BAC8-484D-B476-DF07B1765613Q36135861-B1553FEC-2273-4662-86D2-6D9A4A002B7EQ36351305-FD9147E7-27D2-4515-BFBF-92D62FC04C36Q36363709-C38E2DB9-3E8E-4142-B2FF-E61EE545ABCCQ36466235-D3D7B469-079F-4998-B405-E8F9EC6ECA92Q36466320-08923126-CC38-442D-B9E8-92B8F073D7A3Q36468091-10F07AA6-0844-4495-9FB0-1063FD107CABQ36728787-0703EF6D-2E43-4CDB-9DC2-8C69EBAD7461Q36753327-0A1B1272-4A77-488D-940F-1A8FDFB75668Q36976872-35EF1E3F-16C8-4B5E-8FEF-AA94150B537BQ37474735-AB2526F9-0523-47E2-9379-5673CB4A62A0Q37962343-F729299C-6086-4BB4-A74C-3895E9D72DE4Q38795149-D13D4749-B175-4EF4-B670-2A9109A1A5F9Q39859595-55E243FA-DFF2-4DBB-BEF5-BAE8A839BD9BQ40109875-2F94CCF3-7E3E-42B4-AC57-89EEE411B1A5Q40147134-8AF10BB9-E155-4E1C-8370-5ACE5BFF7F69Q40374044-2A4EE93A-2C0F-4E1F-A963-E14CEAFE0490Q40511940-71B4BD0E-3768-43F0-9FB4-00BE6CC9746DQ40649958-2A4C6C50-4EEC-4446-8784-C4A2FBA92372Q40664515-FAA95C09-D17A-4A5B-80EB-1692DD69CA1DQ41017625-9C8B855B-97AE-4DB7-AE0A-D431346CA286Q41205458-47C13263-23DF-484B-91E9-0A6065B4AA52Q41285833-E944A9B9-2184-4B7D-8A76-778DA97A3488
P2860
The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors
description
1987 nî lūn-bûn
@nan
1987 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
The toxic effects of tumor nec ...... n by cyclooxygenase inhibitors
@ast
The toxic effects of tumor nec ...... n by cyclooxygenase inhibitors
@en
The toxic effects of tumor nec ...... n by cyclooxygenase inhibitors
@nl
type
label
The toxic effects of tumor nec ...... n by cyclooxygenase inhibitors
@ast
The toxic effects of tumor nec ...... n by cyclooxygenase inhibitors
@en
The toxic effects of tumor nec ...... n by cyclooxygenase inhibitors
@nl
prefLabel
The toxic effects of tumor nec ...... n by cyclooxygenase inhibitors
@ast
The toxic effects of tumor nec ...... n by cyclooxygenase inhibitors
@en
The toxic effects of tumor nec ...... n by cyclooxygenase inhibitors
@nl
P2093
P2860
P356
P1476
The toxic effects of tumor nec ...... n by cyclooxygenase inhibitors
@en
P2093
Goldberg AL
Kettelhut IC
P2860
P304
P356
10.1073/PNAS.84.12.4273
P407
P577
1987-06-01T00:00:00Z